Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,666
Closed -$509K 843
2025
Q1
$509K Buy
+5,666
New +$529K 0.08% 405
2024
Q4
Sell
-4,291
Closed -$487K 897
2024
Q3
$487K Buy
+4,291
New +$510K 0.08% 421
2019
Q2
Sell
-14,882
Closed -$1.18M 316
2019
Q1
$1.18M Buy
14,882
+4,297
+41% +$321K 0.11% 96
2018
Q4
$772K Buy
+10,585
New +$747K 0.18% 102
2017
Q4
Sell
-5,184
Closed -$317K 269
2017
Q3
$317K Buy
5,184
+472
+10% +$28.6K 0.1% 118
2017
Q2
$288K Buy
4,712
+630
+15% +$38.4K 0.08% 131
2017
Q1
$247K Sell
4,082
-105
-3% -$6.37K 0.1% 78
2016
Q4
$235K Buy
+4,187
New +$245K 0.1% 70

Other funds holding MRK

Versor Investments's MRK Position: Q2 2025 in Review

Versor Investments sold out of Merck (MRK) in Q2 2025, closing a stake of 5,666 shares — an estimated $509K sold.

Versor Investments first reported a position in MRK in Q4 2016 and held it in 8 quarters. The position peaked at $1.18M in Q1 2019. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Versor Investments reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Versor Investments sold 5,666 Merck shares in Q2 2025, an estimated $509K.
  • Versor Investments first reported a position in Merck in Q4 2016 and held it in 8 quarters.
  • Versor Investments's Merck position peaked at $1.18M in Q1 2019.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Versor Investments's 13F filing for Q2 2025, filed 5 Aug 2025.